Extended Follow-up of Microbiome Therapeutic SER-109 Through 24 Weeks for Recurrent Clostridioides difficile Infection in a Randomized Clinical Trial.
Resource Type
Academic Journal
Authors
Cohen SH; University of California Davis Health, Sacramento.; Louie TJ; Cumming School of Medicine University of Calgary, Calgary, Alberta, Canada.; Sims M; Beaumont Health and Oakland University William Beaumont School of Medicine, Royal Oak, Michigan.; Wang EEL; Seres Therapeutics, Cambridge, Massachusetts.; Memisoglu A; Seres Therapeutics, Cambridge, Massachusetts.; McGovern BH; Seres Therapeutics, Cambridge, Massachusetts.; von Moltke L; Seres Therapeutics, Cambridge, Massachusetts.
Source
Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE